stars 1 stars 2 stars 3

MOLCURE was founded in 2013 with a mission to build the best platform for biologics discovery in the world. Today, its platform integrates AI with evolutionary molecular engineering, next-generation sequencing, laboratory automation technologies, and a proprietary database containing more than one billion molecular entries. These capabilities enable the delivery of diverse, high affinity, specific, and functional antibodies and peptides for researchers. MOLCURE is partnering with innovative companies to discover therapeutics with the potential to benefit patients around the world.

MOLCURE Inc. Questions

The MOLCURE Inc. annual revenue was $1 million in 2026.

Ryu Ogawa is the Founder, CIO(Chief Innovation Officer) of MOLCURE Inc..

17 people are employed at MOLCURE Inc..

MOLCURE Inc. is based in Tokyo, Tokyo.

The NAICS codes for MOLCURE Inc. are [541713, 541, 54, 5417, 54171].

The SIC codes for MOLCURE Inc. are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users